Six year remission of ACTH-dependent Cushing's syndrome using bromocriptine

Postgrad Med J. 1985 Mar;61(713):239-42. doi: 10.1136/pgmj.61.713.239.

Abstract

A patient with ACTH-dependent Cushing's syndrome remained in clinical and biochemical remission six years after pituitary irradiation and while on bromocriptine therapy. When bromocriptine was discontinued urinary free cortisol values became elevated, and were not suppressed by dexamethasone. After reintroduction of the drug, remission was again obtained. It is concluded that bromocriptine is responsible for continuing longterm remission in this case. The possible use of bromocriptine as an adjunctive therapy in ACTH-dependent Cushing's syndrome is discussed.

Publication types

  • Case Reports

MeSH terms

  • Adrenocorticotropic Hormone / blood
  • Adrenocorticotropic Hormone / metabolism*
  • Adult
  • Bromocriptine / therapeutic use*
  • Combined Modality Therapy
  • Cushing Syndrome / drug therapy*
  • Cushing Syndrome / metabolism
  • Cushing Syndrome / radiotherapy
  • Humans
  • Hydrocortisone / metabolism
  • Long-Term Care
  • Male
  • Pituitary Gland / radiation effects

Substances

  • Bromocriptine
  • Adrenocorticotropic Hormone
  • Hydrocortisone